Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe–statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia

By Assmann Gerd   Kannenberg Frank   Ramey Dena R.   Musliner Thomas A.   Gutkin Stephen W.   Veltri Enrico P.  

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 249-259

Informa Healthcare

Access to resources Recommend Favorite

Long-term (48-week) safety of ezetimibe 10 mg/day coadministered with simvastatin compared to simvastatin alone in patients with primary hypercholesterolemia

By Bays Harold   Sapre Aditi   Taggart William   Liu Ji   Capece Rachel   Tershakovec Andrew  

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2953-2966

Informa Healthcare

Access to resources Recommend Favorite

Therapy modifications and low-density lipoprotein cholesterol goal attainment rates associated with the initiation of generic simvastatin

By Willey Vincent J.   Bullano Michael F.   Shoetan Nze N.   Gandhi Sanjay K.  

Current Medical Research and Opinion, Vol. 26, Iss. 1, 2010-01 ,pp. : 121-128

Informa Healthcare

Access to resources Recommend Favorite

Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia

By Daskalopoulou Stella S.   Mikhailidis Dimitri P.  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 2037-2039

Informa Healthcare

Access to resources Recommend Favorite

Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis

By Ose Leiv   Shah Arvind   Davies Michael J.   Rotonda Jennifer   Maccubbin Darbie   Tribble Diane   Veltri Enrico   Mitchel Yale  

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 823-835

Informa Healthcare

Access to resources Recommend Favorite